LOCHOLEST Drug Patent Profile
✉ Email this page to a colleague
When do Locholest patents expire, and when can generic versions of Locholest launch?
Locholest is a drug marketed by Chartwell Rx and is included in two NDAs.
The generic ingredient in LOCHOLEST is cholestyramine. There are eight drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the cholestyramine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Locholest
A generic version of LOCHOLEST was approved as cholestyramine by EPIC PHARMA LLC on August 15th, 1996.
Summary for LOCHOLEST
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | LOCHOLEST at DailyMed |
Pharmacology for LOCHOLEST
Drug Class | Bile Acid Sequestrant |
Mechanism of Action | Bile-acid Binding Activity |
US Patents and Regulatory Information for LOCHOLEST
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chartwell Rx | LOCHOLEST | cholestyramine | POWDER;ORAL | 074561-001 | Aug 15, 1996 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Chartwell Rx | LOCHOLEST LIGHT | cholestyramine | POWDER;ORAL | 074562-002 | Aug 15, 1996 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Chartwell Rx | LOCHOLEST | cholestyramine | POWDER;ORAL | 074561-002 | Aug 15, 1996 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |